# Yuimedi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yuimedi

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: https://yuimedi.com
- Total disclosed funding: $3.3M
- Latest round: Series A (Nov 30, 2022)
- Investors on record: 6

## About

Founded in 2020 and based in Tokyo, Japan, Yuimedi, Inc., d.b.a. Yuimedi, operates as a company that provides infrastructure for accessing, standardizing, and using medical data, connecting medical institutions with data users, enabling data extraction, analytics, and software services to support research, clinical operations, and pharmaceutical activities across healthcare systems globally.

In May 2026, Yuimedi raised JPY 200 million in venture funding from Norinchukin Capital and Darwin Venture Management. This round was part of a larger JPY 600 million venture funding round.

The company provides its products, Yuicleaner, which is a no code data cleaning software specialising in medical data that works safely in a closed network. Yuicleaner features include standardization, visualising errors, and supporting the anonymization process. The firm offers solutions such as data cleaning for medical data analysis, a network to connect data providers and researchers, and human resource development to assist people in the digital healthcare industry.

The company will use the May 2026 funding to accelerate business growth and organizational scaling including hiring and product development.

## Funding rounds

- Series A, Nov 30, 2022, $3.3M — Incubate Fund, Nissay Capital, D4V, DG Daiwa Ventures, Coral Capital, Chiba Dojo

## Investors

- Incubate Fund (https://capitalatlas.ai/funds/incubate-fund) — Series A
- Nissay Capital (https://capitalatlas.ai/funds/nissay-capital) — Series A
- D4V (https://capitalatlas.ai/funds/d4v) — Series A
- DG Daiwa Ventures (https://capitalatlas.ai/funds/dg-daiwa-ventures) — Series A
- Coral Capital — Series A
- Chiba Dojo (https://capitalatlas.ai/funds/chiba-dojo) — Series A